• Citer

Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule.

par Awada, Ahmad ;Punt, Cornelis;Piccart-Gebhart, Martine ;Van Tellingen, Olaf;Van Manen, Lori;Kerger, Joseph ;Groot, Yvonne;Wanders, Jantien;Verweij, Jaap;Wagener, Th
Référence British Journal of Cancer, 79, 9-10, page (1454-1461)
Publication Publié, 1999-03

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule.
Auteur:	Awada, Ahmad; Punt, Cornelis; Piccart-Gebhart, Martine; Van Tellingen, Olaf; Van Manen, Lori; Kerger, Joseph; Groot, Yvonne; Wanders, Jantien; Verweij, Jaap; Wagener, Th
Informations sur la publication:	British Journal of Cancer, 79, 9-10, page (1454-1461)
Statut de publication:	Publié, 1999-03
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Antineoplastic Agents -- administration & dosage
	Antineoplastic Agents -- adverse effects
	Antineoplastic Agents -- pharmacokinetics
	Benzofurans -- administration & dosage
	Benzofurans -- adverse effects
	Benzofurans -- pharmacokinetics
	Dose-Response Relationship, Drug
	Drug Administration Schedule
	Female
	Follow-Up Studies
	Humans
	Indoles -- administration & dosage
	Indoles -- adverse effects
	Indoles -- pharmacokinetics
	Infusions, Intravenous
	Male
	Middle Aged
	Neoplasms -- drug therapy
	Neoplasms -- metabolism
	Neoplasms -- pathology
	Neutropenia -- chemically induced
	Prodrugs -- administration & dosage
	Prodrugs -- adverse effects
	Thrombocytopenia -- chemically induced
Note générale:	Clinical Trial
	Clinical Trial, Phase I
	Journal Article
Langue:	Anglais
Identificateurs:	urn:issn:0007-0920
	info:doi/10.1038/sj.bjc.6690232
	info:pmid/10188890
	PMC2362731